Steven Rosenberg (left) is a Senior Investigator and Chief of the Surgical procedure Department on the Nationwide Most cancers Institute (NCI; MD, USA). Rosenberg pioneered the event of efficient immunotherapies for sufferers with superior most cancers, together with his work contributing to IL-2, TIL and CAR-T therapies. Rosenberg lately received the 2024 AACR Award for Lifetime Achievement in Most cancers Analysis, and we obtained the prospect to take a seat down with him to speak about his fascinating profession and the methods which have formed it. Right here, he discusses his work researching and growing immunotherapies, what he’s presently focussed on, and the traits it is advisable to thrive…
To view this content material, please register now for entry
Be part of our member group for FREE to entry a group of journal and online-only options, together with:
- Unique entry to instructional movies, eBooks and insights into prime BioTechniques journal articles
- The newest information and journal updates delivered straight to your inbox while you need it
- Customized suggestions for the newest member-exclusive podcasts, interviews and skilled opinions
- Precedence registration to webinars, panel discussions and occasions
- Entry to competitions and journal publication reductions, together with 10% off open entry charges while you join at this time!
